Medikografi   Nootropics

Creatine

​

Meta-Analysis of Creatine for Neuroprotection Against Parkinson's Disease.

 

Recent advances in perinatal neuroprotection.

 

Creatine for neuroprotection in neurodegenerative disease: end of story?

 

Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials.

 

Creatine as a Neuroprotector: an Actor that Can Play Many Parts.

 

Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation.

 

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

 

Creatine for Parkinson's disease.

 

Neuroprotective effects of creatine.

 

Creatine as a booster for human brain function. How might it work?

 

Creatine in mouse models of neurodegeneration and aging.

 

Creatine for amyotrophic lateral sclerosis/motor neuron disease.

 

Creatine for amyotrophic lateral sclerosis/motor neuron disease.

 

Creatine affords protection against glutamate-induced nitrosative and oxidative stress.

 

Synthesis and transport of creatine in the CNS: importance for cerebral functions.

 

The CREST-E study of creatine for Huntington disease: A randomized controlled trial.

 

A Prophylactic Role for Creatine in Hypoxia?

 

The possible beneficial effects of creatine for the management of depression.

 

Drug treatment for spinal muscular atrophy types II and III.

 

Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.

 

The neuroprotective role of creatine.

 

Mitochondrial approaches for neuroprotection.

 

Argininosuccinate neurotoxicity and prevention by creatine in argininosuccinate lyase deficiency: An in vitro study in rat three-dimensional organotypic brain cell cultures.

 

The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders.

 

Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives.

 

Progress in neuroprotection in Parkinson's disease.

 

Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?

 

Clinical trials of neuroprotection for Parkinson's disease.

 

Bioenergetic approaches for neuroprotection in Parkinson's disease.

 

Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency.

 

A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis.

 

Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.

 

Potential benefits of creatine monohydrate supplementation in the elderly.

 

The biological basis of injury and neuroprotection in the fetal and neonatal brain.

 

Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity.

 

Does supplemental creatine prevent herpes recurrences?

 

Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.

 

Few adverse effects of long-term creatine supplementation in a placebo-controlled trial.

 

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

 

Creatine supplementation lowers brain glutamate levels in Huntington's disease.

 

Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways.

 

Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.

 

Metabolic agents that enhance ATP can improve cognitive functioning: a review of the evidence for glucose, oxygen, pyruvate, creatine, and L-carnitine.

 

Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.

 

Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q.

 

Long-term creatine supplementation is safe in aged patients with Parkinson disease.

 

The effect of creatine and coenzyme q10 combination therapy on mild cognitive impairment in Parkinson's disease.

 

The modulation of NMDA receptors and L-arginine/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test.

 

Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study.

 

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

 

Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.

 

Targeting cellular energy production in neurological disorders.

 

Preventing childhood and lifelong disability: Maternal dietary supplementation for perinatal brain injury.

 

The ongoing pursuit of neuroprotective therapies in Parkinson disease.

 

Reduced N-acetylaspartate to creatine ratio in the posterior cingulate correlates with cognition in Alzheimer's disease following four months of rivastigmine treatment.

 

Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition.

 

Upcoming treatments in Parkinson's disease, including gene therapy.

 

Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study.

 

A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.

 

S-adenosyl-L-methionine restores photoreceptor function following acute retinal ischemia.

 

Attenuation of rotenone-induced mitochondrial oxidative damage and neurotoxicty in Drosophila melanogaster supplemented with creatine.